← All sarcoma trials
Recruiting now—All ages

An Observational Study on Epithelioid Sarcoma

Sponsor: Italian Sarcoma Group · NCT03099681 on ClinicalTrials.gov ↗

Bring this to your care team →

Conditions studied

Epithelioid Sarcoma

What it tests

  • Treatment for Epitheloid Sarcomaother

Where it's running11 sites

11 international sites

  • Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori - IRST

    Meldola, FC, Italy

    Recruiting now
    • Lorella Gurreri, MD(contact)

  • Istituto Europeo di Oncologia

    Milan, MI, Italy 20141

    Recruiting now
    • Elisabetta Setola, MD(principal investigator)

  • Istituto Clinico Humanitas

    Rozzano, MI, Italy 20089

    Recruiting now
    • Alexia Bertulli, MD(principal investigator)

  • Azienda Ospedaliera Universitaria Paolo Giaccone

    Palermo, PA, Italy 90127

    Recruiting now
    • Antonio Russo, MD(principal investigator)

  • Fondazione del Piemonte per l'Oncologia IRCC Candiolo

    Candiolo, Torino, Italy 10060

    Recruiting now
    • Giovanni Grignani, MD(principal investigator)

  • Istituto Ortopedico Rizzoli - Unit of Chemotherapy of Muscoloskeletal Tumors

    Bologna, Italy 40136

    Recruiting now

  • Fondazione IRCCS INT Milano

    Milan, Italy

    Recruiting now

  • Irccs Istituto Oncologico Veneto (Iov)

    Padova, Italy

    Recruiting now
    • Antonella Brunello, MD(contact)
    • Antonella Brunello, MD(principal investigator)

  • Ospedale Misericordia e Dolce Ist. Toscano Tumori, Az. USL4

    Prato, Italy 59100

    Recruiting now
    • Giacomo G Baldi, MD(principal investigator)

  • Campus Biomedico

    Roma, Italy

    Recruiting now
    • Bruno Vincenzi, MD(contact)

  • Istituti Fisioterapici Ospitalieri di Roma

    Roma, Italy

    Recruiting now
    • Virginia Ferraresi, MD(contact)
    • Virginia Ferraresi, MD(principal investigator)
See the official eligibility language

Shown exactly as written on ClinicalTrials.gov. Your oncologist is the right person to judge whether it fits your situation.

Inclusion criteria

1. Histological diagnosis of epithelioid sarcoma according to 2014 World Health Organization (WHO) classification, performed on biopsy or surgical specimen
2. Signed informed consent
3. Adequate patient compliance to treatment or follow up
4. No age limit

Exclusion criteria

1. Other malignancies within past 5 years, with exception of carcinoma in situ of the cervix and basocellular skin cancers treated with eradicating intent
2. Impossibility to ensure adequate compliance

Updated 2025-11-18 on ClinicalTrials.gov. Always confirm current details with the study team or your oncologist.